QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Cryoport, Inc. (CYRX)

Industrials

Actionable
Fundamental
3
Sentiment
3
Technical
4

Bullish pullback_to_support: buy limit 19.50, just above the 2026-11-13 regular-session swing low 19.42 and EMA9 19.33, inside a post-earnings uptrend (price 19.89 above SMA20/50/200 in a bullish stack, MACD +0.28 expanding, RSI14 61.0) after a three-session retracement on contracting volume; structure-based stop 18.40 sits 1.0×ATR below entry (Change-A pullback floor, min-risk floor 0.5×ATR cleared with riskInATR 1.00), targets 21.70 / 23.35, R/R 2.00, and no earnings or dividend event falls inside the 15-trading-day holding window.

Analysis as of 2026-11-15· more than 2 trading days ago

Company overview

Cryoport, Inc. provides temperature-controlled supply chain solutions for the life sciences sector, operating globally. Their services include logistics management through Cryoportal, real-time shipment tracking, and biological specimen management. The company serves biopharmaceutical, animal health, and human reproductive medicine industries.

Fundamental

fair
Fundamental3
Mixed fundamentals

Cryoport shows an operating turnaround with positive cash flow, but GAAP losses and dilution remain concerns.

A mixed picture with a genuine operating turnaround underneath: continuing-operations revenue grew 12.4% in FY2025 and again in the first nine months of 2026, adjusted EBITDA and operating cash flow both turned positive, and a net-cash balance sheet covers the $186.2 million December 2026 convertible maturity more than twice with no covenants and no going-concern language. Against that, GAAP operating losses persist, free cash flow is still negative because capital spending outruns operating cash flow, the shares trade near five times sales with no earnings support, and heavy dilution plus steady insider selling weigh on the equity. FY2025's positive net income was a one-time divestiture gain, not an operating result.

Sentiment

fair
Sentiment3
Two-sided sentiment

Sentiment is mixed with positive earnings growth offset by a downgrade and financing concerns.

The dominant near-term driver is the announced 2026-11-05 Q3 print — revenue +14% YoY to $50.2M with FY2026 revenue guidance raised to $197–199M — which the tape visibly rewarded (roughly 20% post-print rally and a break above the 50-day moving average), set against a 2026-11-09 Seeking Alpha downgrade and a December debt-repayment overhang, so the signal set is genuinely two-sided. Sentiment delta is indeterminate because both windows scored below the three-item threshold (scoring n=1 at +0.50, baseline n=2 at +0.25); the conflicting-catalysts moderate red-flag cap applies (ceiling of 3) and no severe flag fired.

Technical

good
Technical4
Post-earnings uptrend

The stock is in an uptrend, holding above key moving averages with positive momentum indicators.

Score 4 — trend, momentum and volume frames all confirm, with trend strength the single weak signal. Price 19.89 sits above every moving average in a fully bullish stack (EMA9 19.33 > EMA21 18.49 > SMA20 18.27 > SMA50 17.43 > SMA200 13.71) and above the daily VWAP 19.80; MACD is positive and above its signal with an expanding histogram (0.75 / 0.47 / +0.28); RSI14 has recovered from 40.0 on 2026-11-05 to 61.0 without becoming overbought; Williams %R has unwound from −95.0 (11-02) to −30.1. Volume confirms accumulation: post-results sessions traded 2.12M–2.96M shares while the three-day retracement volume faded to 1.20M / 0.66M / 0.41M, and 20-day dollar volume is $23.25M against a $5M floor. The one weak signal is ADX14 at 23.3 — rising but still under 25, so this is a young advance rather than an established trend — and the last three sessions printed lower closes before Friday's 19.42 → 19.89 recovery. The chart pattern is a pullback to support within that uptrend; the fixed-risk structure (1.0×ATR stop against a 2.0×ATR first target) yields R/R 2.00.

You’re looking at 2026-11-15 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.